More targeted antibody therapies carry the potential to transform how physicians treat inflammatory bowel disease. However, management can become less clear when IBD patients present with extra-intestinal manifestations. Extra-intestinal manifestations of inflammatory bowel disease can leave gastroenterologists wondering about the best approach to treatment.

Read More